Group One Trading’s Co-Diagnostics CODX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.7K Buy
17,600
+16,803
+2,108% +$57.4K ﹤0.01% 5593
2025
Q4
$4.03K Buy
797
+794
+26,467% +$8.64K ﹤0.01% 7268
2025
Q3
$34 Buy
+3
New +$28 ﹤0.01% 8267
2025
Q1
Sell
-2,100
Closed -$47.3K 7689
2024
Q4
$47.3K Sell
2,100
-303
-13% -$9.57K ﹤0.01% 5093
2024
Q3
$90.1K Buy
2,403
+400
+20% +$15.4K ﹤0.01% 4254
2024
Q2
$75.1K Sell
2,003
-457
-19% -$16.6K ﹤0.01% 4191
2024
Q1
$82.7K Sell
2,460
-2,383
-49% -$86.3K ﹤0.01% 4309
2023
Q4
$193K Buy
4,843
+2,410
+99% +$85K ﹤0.01% 3896
2023
Q3
$77.4K Buy
2,433
+26
+1% +$982 ﹤0.01% 4693
2023
Q2
$80.1K Sell
2,407
-20
-0.8% -$765 ﹤0.01% 4839
2023
Q1
$108K Sell
2,427
-436
-15% -$35K ﹤0.01% 4253
2022
Q4
$216K Sell
2,863
-1,254
-30% -$117K ﹤0.01% 3798
2022
Q3
$396K Buy
4,117
+250
+6% +$35K ﹤0.01% 3464
2022
Q2
$651K Sell
3,867
-1,330
-26% -$202K ﹤0.01% 3182
2022
Q1
$963K Buy
5,197
+890
+21% +$184K ﹤0.01% 3116
2021
Q4
$1.15M Buy
4,307
+2,380
+124% +$624K ﹤0.01% 3212
2021
Q3
$562K Sell
1,927
-1,260
-40% -$368K ﹤0.01% 4051
2021
Q2
$789K Sell
3,187
-2,430
-43% -$625K ﹤0.01% 3673
2021
Q1
$1.61M Sell
5,617
-6,100
-52% -$2.43M ﹤0.01% 2703
2020
Q4
$3.27M Buy
11,717
+5,120
+78% +$1.9M 0.01% 1632
2020
Q3
$2.69M Sell
6,597
-7,010
-52% -$3.6M 0.01% 1369
2020
Q2
$7.9M Buy
13,607
+11,620
+585% +$5.3M 0.04% 556
2020
Q1
$454K Buy
+1,987
New +$345K ﹤0.01% 2119

Other funds holding CODX

Group One Trading's CODX Position: Q4 2025 in Review

Group One Trading sold out of Co-Diagnostics (CODX) in Q4 2025, closing a stake of 1,810 shares — an estimated $19.7K sold.

Group One Trading first reported a position in CODX in Q1 2021 and held it in 16 quarters. The position peaked at $657K in Q1 2021. 30 funds tracked by Wall St. Rank hold CODX as of Q4 2025.

  • Group One Trading reported no remaining Co-Diagnostics position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 1,810 Co-Diagnostics shares in Q4 2025, an estimated $19.7K.
  • Group One Trading first reported a position in Co-Diagnostics in Q1 2021 and held it in 16 quarters.
  • Group One Trading's Co-Diagnostics position peaked at $657K in Q1 2021.
  • 30 funds tracked by Wall St. Rank held Co-Diagnostics as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.